Statements in Support of Testosterone Treatment Options for Menopausal Women

These statements and their authors are not affiliated with Eido Bio and any products currently in development.

James A. Simon, MD

Clinical Professor of Obstetrics and Gynecology 
George Washington University 

“There are 31 approved testosterone products for men, and none approved for women.” 

Dr. Mary Claire Haver, MD — Board-certified OB/GYN, NYT bestselling author of The New Menopause, Adjunct Professor at UT Medical Branch 

"We have robust data showing that testosterone can significantly improve the overall quality of life in women in midlife. And yet, in the U.S., there is still no FDA-approved testosterone product specifically for women, despite our bodies naturally producing it. We're not asking for more than what men already have. We're asking for equity, science, and respect." 

“In an ideal world, there would be an FDA-approved testosterone patch for women.” 

Source: Dr. Mary Claire Haver, TikTok / @drmaryclairehaver (December 2025)

 Dr. Traci Kurtzer, MD — Gynecologist, Northwestern Medicine Center for Sexual Medicine and Menopause 

"It would be really nice if we did have an FDA-approved product for women that was dosed appropriately." 

Source: TIME Magazine, "Testosterone Therapy Is Trending—for Women. Here's What to Know," February 19, 2025

Dr. Sharon J. Parish, MD & Dr. Susan R. Davis, MBBS, PhD — Professor of Medicine at Weill Cornell Medical College (Parish); Professor and head of the Women's Health Research Program, Monash University (Davis); lead authors of the ISSWSH Clinical Practice Guideline 

"Despite substantial evidence regarding safety, efficacy, and clinical use, access to testosterone therapy for the treatment of HSDD in women remains a significant unmet need." 

Source: International Society for the Study of Women's Sexual Health (ISSWSH) Clinical Practice Guideline, Journal of Sexual Medicine, 2021 (Parish SJ, Simon JA, Davis SR, et al.)

Cleveland Clinic Journal of Medicine Editorial Board

"Hopefully, with growing clarity regarding the evidence of safety and efficacy of testosterone in women with HSDD, a testosterone formulation for women will join the list of FDA-approved products." 

Source: Cleveland Clinic Journal of Medicine, Vol. 88, No. 1, January 2021

Juliana M. Kling, MD, MPH, NCMP, FACP and Sharon J. Parish, MD 

Cleveland Clinic Journal of Medicine January 2021, 88 (1) 44-46; DOI: https://doi.org/10.3949/ccjm.88a.20195

Contemporary OB/GYN Clinical Experts Panel

"Panelists collectively urged the FDA to remove or revise boxed warnings for low-dose vaginal estrogen and to support regulatory pathways for female-specific testosterone products." One panelist concluded: "Women deserve policy that reflects the current evidence and not outdated myths." 

Source: Contemporary OB/GYN, reporting on the FDA Expert Roundtable on Menopause and HRT, January 2026

Dr. Kelly Casperson, MD — Board-certified urologist, women's sexual health advocate, author of You Are Not Broken

"One in 5 men are diagnosed with hypogonadism… nearly all women experience the same hormone decline when they live long enough," arguing that the absence of a female-specific FDA-approved testosterone formulation represents a regulatory and equity failure. 

Source: Contemporary OB/GYN, reporting on FDA Expert Roundtable on Menopause and HRT, July 2025

Lauren Streicher, MD

Clinical Professor of Obstetrics and Gynecology 
Northwestern University Feinberg School of Medicine 

“While there has been no FDA-approved testosterone for women, we have good data showing that it can be safe and effective.”

Contemporary OB/GYN Clinical Experts Panel

"Panelists collectively urged the FDA to remove or revise boxed warnings for low-dose vaginal estrogen and to support regulatory pathways for female-specific testosterone products." One panelist concluded: "Women deserve policy that reflects the current evidence and not outdated myths."

Source: Contemporary OB/GYN, reporting on the FDA Expert Roundtable on Menopause and HRT, January 2026